Stock Name: KPJ
Company Name: KPJ HEALTHCARE BHD
Company Name: KPJ HEALTHCARE BHD
| Research House: MIDF | Price Call: HOLD | Target Price: 4.05 |
Showing posts with label KPJ. Show all posts
Showing posts with label KPJ. Show all posts
March 2, 2015
October 7, 2014
November 20, 2013
September 19, 2013
July 30, 2013
Bonus and rights issue
Stock Name: KPJ
Company Name: KPJ HEALTHCARE BHD
Company Name: KPJ HEALTHCARE BHD
| Research House: ALLIANCE | Price Call: SELL | Target Price: 6.05 |
July 29, 2013
July 23, 2013
KPJ - Profitability affected by aggressive growth
Stock Name: KPJ
Company Name: KPJ HEALTHCARE BHD
Company Name: KPJ HEALTHCARE BHD
| Research House: MIDF | Price Call: HOLD | Target Price: 6.34 |
April 18, 2013
Acquired Rawang Specialist Hospital
Stock Name: KPJ
Company Name: KPJ HEALTHCARE BHD
Company Name: KPJ HEALTHCARE BHD
| Research House: MIDF | Price Call: BUY | Target Price: 6.55 |
March 1, 2013
Short-term pain on the way to regional dominance
Stock Name: KPJ
Company Name: KPJ HEALTHCARE BHD
Company Name: KPJ HEALTHCARE BHD
| Research House: MIDF | Price Call: BUY | Target Price: 6.55 |
December 18, 2012
Sutaining growth momentum
Stock Name: KPJ
Company Name: KPJ HEALTHCARE BHD
Company Name: KPJ HEALTHCARE BHD
| Research House: MIDF | Price Call: BUY | Target Price: 6.86 |
November 30, 2012
Profitability hit by overseas operations
Stock Name: KPJ
Company Name: KPJ HEALTHCARE BHD
Company Name: KPJ HEALTHCARE BHD
| Research House: MIDF | Price Call: BUY | Target Price: 6.86 |
September 13, 2012
Another hospital on deck
Stock Name: KPJ
Company Name: KPJ HEALTHCARE BHD
Company Name: KPJ HEALTHCARE BHD
| Research House: MIDF | Price Call: BUY | Target Price: 6.98 |
August 9, 2012
MIDF upbeat on KPJ's RM3.59m land sale
Stock Name: KPJ
Company Name: KPJ HEALTHCARE BHD
KUALA LUMPUR: MIDF Research is positive on KPJ Healthcare
Bhd's sale and purchase agreement with Al-Aqra Healthcare Real Estate Investment Trust to dispose two pieces of land in Johor Baru for RM3.59 million.
The agreement was signed by KPJ Healthcare's wholly-owned subsidiary, Puteri Specialist Hospital (Johor) Sdn Bhd.
The research house said the agreement would pave the way for Puteri Specialist Hospital's expansion in consistent with KPJ Healthcare's asset light strategy.
"Based on its proven track record, we're confident the company's management will be able to sustain KPJ Healthcare's growth momentum, maintaining its top line growth rate and preserving its profitability.
"KPJ Healthcare is expected to gain RM1.53 million from the disposal, resulting in 0.27 sen improvement in earnings per share for the 2012 revenue," it said in a research note.
MIDF Research said KPJ Healthcare's share price saw strong positive movements over the last few months, which they believe was part of the positive spillover effects from IHH Healthcare's dual listing recently.
However, due to KPJ Healthcare's growth potential, the research house believes there was still ample upside for the stock in the long run.
The research firm maintained "buy" recommendation for KPJ Healthcare, with RM6.98 unchanged target price. -- BERNAMA
Company Name: KPJ HEALTHCARE BHD
| Research House: MIDF | Price Call: BUY | Target Price: 6.98 |
KUALA LUMPUR: MIDF Research is positive on KPJ Healthcare
Bhd's sale and purchase agreement with Al-Aqra Healthcare Real Estate Investment Trust to dispose two pieces of land in Johor Baru for RM3.59 million.
The agreement was signed by KPJ Healthcare's wholly-owned subsidiary, Puteri Specialist Hospital (Johor) Sdn Bhd.
The research house said the agreement would pave the way for Puteri Specialist Hospital's expansion in consistent with KPJ Healthcare's asset light strategy.
"Based on its proven track record, we're confident the company's management will be able to sustain KPJ Healthcare's growth momentum, maintaining its top line growth rate and preserving its profitability.
"KPJ Healthcare is expected to gain RM1.53 million from the disposal, resulting in 0.27 sen improvement in earnings per share for the 2012 revenue," it said in a research note.
MIDF Research said KPJ Healthcare's share price saw strong positive movements over the last few months, which they believe was part of the positive spillover effects from IHH Healthcare's dual listing recently.
However, due to KPJ Healthcare's growth potential, the research house believes there was still ample upside for the stock in the long run.
The research firm maintained "buy" recommendation for KPJ Healthcare, with RM6.98 unchanged target price. -- BERNAMA
July 30, 2012
MIDF raises KPJ Healthcare to 'buy'
Stock Name: KPJ
Company Name: KPJ HEALTHCARE BHD
KUALA LUMPUR: MIDF Research raised its call on KPJ Healthcare Bhd to 'buy' on the back of a brighter outlook due to the firm's expansion plans and resilient growth in the country's private healthcare industry.
"Based on its proven track record, we are confident that the company's management will be able to sustain KPJ's growth momentum, maintaining its top line growth rate and preserving its profitability," MIDF said in a note today.
The research house said KPJ's share has seen strong positive momentum in the past few months, which could have been partly due to the spillover effect from IHH Healthcare Bhd's dual listing.
"With this catalyst, we expect KPJ to no longer trade at a discount to its peers, but should fetch the same valuation to its regional peers," MIDF added.
MIDF also raised its target price to RM6.98 per share from RM5.10 previously.
As of 0125 GMT, shares in KPJ gained 1.2 per cent against the Malaysian benchmark stock index's 0.17 per cent rise. -- Reuters
Company Name: KPJ HEALTHCARE BHD
| Research House: MIDF | Price Call: BUY | Target Price: 6.98 |
KUALA LUMPUR: MIDF Research raised its call on KPJ Healthcare Bhd to 'buy' on the back of a brighter outlook due to the firm's expansion plans and resilient growth in the country's private healthcare industry.
"Based on its proven track record, we are confident that the company's management will be able to sustain KPJ's growth momentum, maintaining its top line growth rate and preserving its profitability," MIDF said in a note today.
The research house said KPJ's share has seen strong positive momentum in the past few months, which could have been partly due to the spillover effect from IHH Healthcare Bhd's dual listing.
"With this catalyst, we expect KPJ to no longer trade at a discount to its peers, but should fetch the same valuation to its regional peers," MIDF added.
MIDF also raised its target price to RM6.98 per share from RM5.10 previously.
As of 0125 GMT, shares in KPJ gained 1.2 per cent against the Malaysian benchmark stock index's 0.17 per cent rise. -- Reuters
May 15, 2012
PublicInvest starts KPJ with 'outperform'
Stock Name: KPJ
Company Name: KPJ HEALTHCARE BHD
PublicInvest Research started KPJ Healthcare Bhd with an "outperform" call and target price of RM7.14 per share, citing plenty of room for growth for the Malaysia's largest healthcare provider going forward.
"We like KPJ for its proven track record of growing its revenue and earnings consistently for the past ten years, the recession-proof nature of its business and promising long-term growth prospects," the broker said in a research note on Tuesday.
PublicInvest said KPJ enjoyed the benefits of a captive market as patients do not have other choices for private healthcare unless they travel to other places.
"As the main private hospital in Malaysia, KPJ also stands to benefit from the spillover effect of overcrowded public hospitals," it added.
By 9.32am, KPJ's shares was unchanged at RM5.78 per share, as compared with the Malaysia's benchmark stock index that dropped 1 percent. -- Reuters
Company Name: KPJ HEALTHCARE BHD
| Research House: PUBLIC BANK | Price Call: BUY | Target Price: 7.14 |
PublicInvest Research started KPJ Healthcare Bhd with an "outperform" call and target price of RM7.14 per share, citing plenty of room for growth for the Malaysia's largest healthcare provider going forward.
"We like KPJ for its proven track record of growing its revenue and earnings consistently for the past ten years, the recession-proof nature of its business and promising long-term growth prospects," the broker said in a research note on Tuesday.
PublicInvest said KPJ enjoyed the benefits of a captive market as patients do not have other choices for private healthcare unless they travel to other places.
"As the main private hospital in Malaysia, KPJ also stands to benefit from the spillover effect of overcrowded public hospitals," it added.
By 9.32am, KPJ's shares was unchanged at RM5.78 per share, as compared with the Malaysia's benchmark stock index that dropped 1 percent. -- Reuters
April 20, 2012
KPJ Healthcare: Naim Holdings expands into healthcare
Stock Name: KPJ
Company Name: KPJ HEALTHCARE BHD
Naim Holdings's wholly-owned unit, Naim Land Sdn Bhd (NLSB), had signed a JV agreement with KPJ Healthcare unit Kumpulan Perubatan (Johor) Sdn Bhd (KPJSB) for a hospital project in Miri, Sarawak. The JV company (JV Co) will have an initial authorized share capital of RM25m and an initial paid-up capital of RM19.67m. KPJSB will hold 70% of the JV Co and NLSB the balance. KPJSB will be allotted 13.77m shares or RM13.67m via a cash injection, to be financed via internally generated funds. NLSB will subscribe to 5.9m shares of JV Co or RM5.9m via an injection of a four-acre (1.6ha) land. The land on which the hospital will be built is under NLSB. Under the agreement, Naim Engineering Sdn Bhd will be engaged as the contractor to build and complete the hospital. KPJSB will be the master planner and project manager to advise on the design and technical requirements of the building. (Financial Daily)
Comment: This latest corporate development is in line with KPJ's objective to increase 1-2 new hospitals every year. Currently, there are 2 hospitals owned by KPJ in Sarawak. As the new hospital is expected to be completed only in 2-3 years, we maintain our FY12 and FY13 earnings forecast. KPJ's RM13.8m portion of the paid-up capital is a small dent to KPJ's net gearing of 0.2x as at 31 Dec 2011. Maintain a HOLD with TP of RM4.96 based on 22x FD FY12 EPS, in line with peers' average. (Raymond Choo)
Company Name: KPJ HEALTHCARE BHD
| Research House: ECMLIBRA | Price Call: HOLD | Target Price: 4.96 |
Naim Holdings's wholly-owned unit, Naim Land Sdn Bhd (NLSB), had signed a JV agreement with KPJ Healthcare unit Kumpulan Perubatan (Johor) Sdn Bhd (KPJSB) for a hospital project in Miri, Sarawak. The JV company (JV Co) will have an initial authorized share capital of RM25m and an initial paid-up capital of RM19.67m. KPJSB will hold 70% of the JV Co and NLSB the balance. KPJSB will be allotted 13.77m shares or RM13.67m via a cash injection, to be financed via internally generated funds. NLSB will subscribe to 5.9m shares of JV Co or RM5.9m via an injection of a four-acre (1.6ha) land. The land on which the hospital will be built is under NLSB. Under the agreement, Naim Engineering Sdn Bhd will be engaged as the contractor to build and complete the hospital. KPJSB will be the master planner and project manager to advise on the design and technical requirements of the building. (Financial Daily)
Comment: This latest corporate development is in line with KPJ's objective to increase 1-2 new hospitals every year. Currently, there are 2 hospitals owned by KPJ in Sarawak. As the new hospital is expected to be completed only in 2-3 years, we maintain our FY12 and FY13 earnings forecast. KPJ's RM13.8m portion of the paid-up capital is a small dent to KPJ's net gearing of 0.2x as at 31 Dec 2011. Maintain a HOLD with TP of RM4.96 based on 22x FD FY12 EPS, in line with peers' average. (Raymond Choo)
Source: ECM Newz Bits 20 April 2012
KPJ (FV RM5.84 - BUY) Corporate News Flash: Heading For Miri
Stock Name: KPJ
Company Name: KPJ HEALTHCARE BHD
Company Name: KPJ HEALTHCARE BHD
| Research House: OSK | Price Call: BUY | Target Price: 5.84 |
THE BUZZ
Yesterday, KPJ announced on Bursa Malaysia that it has entered into a Joint Venture Agreement(JVA) with Naim Land SB (NLSB) todesign, develop, build, complete and own a purpose-built hospital building in Miri, Sarawak as well asoperate this new hospital subsequently.
OUR TAKE
More on the JV. Under the JVA, KPJ will hold a 70% stake, with NLSB holding the remaining 30% stake.Pursuant to the JVA, NLSB will disposeof a piece of land measuring 4 acres in Kuala Baram Land District in Miriwith vacant possession given for the building of the proposed hospital, while KPJSB will provide the technical and management servicesfor the construction of the hospital building as well as assist the JV companyin matters relating to the construction and completion of the building. The name of the proposed hospital will be mutually agreed on by both parties in the future. We gather that the hospital will have a capacityof about 120 beds. While the total cost of setting up the proposed hospital wasnot disclosed, we believe that based on its bed capacity, the cost could range from RM80m to RM100m. Based on KPJ's standard practice, the proposed hospital will most likely commence operation with an initial capacity of between 60 and 90 beds.
Bigger footprint inEast Malaysia. Upon completion, thehospital will be KPJ's 3rd hospital in Sarawak and its fifth in EastMalaysia. We view the proposed JV positively as this move is in line with KPJ'sstrategy to increase its presence in East Malaysia in light of this region'sunderserved market and untapped potential for private hospitals. We gather there are currently several privatehospitals in Miri but most of them are small in size. We think there is strongdemand for private healthcare in Miri, which has a population of about 300,000 and a vibrant economy that isunderpinned by the oil and gas industry. That said, given Miri's proximityto Brunei, there is also potential for the proposed hospital to treatpatients from that country.
Maintain Buy. We maintain our Buy recommendation on KPJ, atan unchanged fair value of RM5.84, based on a FY12 PER of 23.1x. This multiple is derivedfrom the market cap-weighted average regional sector PER. We have always viewed KPJ as a stock with a compellinggrowth story which is further reinforced by the fact that it is in a relatively defensive sector. As such, we reiterate our view that the stock makes an excellent long-term investment.
Source: OSK188
Subscribe to:
Posts (Atom)